Beam Ther­a­peu­tics gave an ini­tial look at the first hand­ful of pa­tients who re­ceived its ex­per­i­men­tal gene-edit­ed treat­ment for sick­le cell dis­ease.

Beam has adopted a similar trial design to the studies that supported the approvals of Casgevy and bluebird bio’s Lyfgenia. The precedents suggest Beam could win approval with data on 30 patients.

A patient with sickle cell disease died while participating in a clinical trial of a CRISPR-based treatment from Beam Therapeutics, threatening to overshadow early signals of effective gene editing.

Naturally, after enlisting other Japanese designers like noir kei ninomiya and POTR (Porter Yoshida & co‘s sub-label) to reimagine the model, Reebok has called in BEAMS to put its spin on the ...

A medicine built around a more precise form of CRISPR gene editing appeared to work as designed in its first clinical trial test, developer Beam Therapeutics said Tuesday. But the death of a trial ...

They then emit microwaves that can merge into a powerful energy beam to attack one target. This is similar to the Death Star seen in the Star Wars films. To build up the energy required to destroy ...

Israel's "Iron Beam," a laser defense system to counter missiles, drones, and other aerial threats, is set to become operational next year. Developed alongside the Iron Dome, this innovative ...

The Iron Beam can engage at the speed of light from a range of hundreds of meters to several kilometers. Israel's 'Iron Beam', designed to use high-power laser to down projectiles, will be ...

One of the main connections between Cincinnati and Northern Kentucky could be closed for weeks after a fire under the Daniel Carter Beard Bridge damaged its steel structure, officials said Friday.